Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epilepsy in Aging Populations.

Mercedes P. Jacobson1

  • 1Department of Neurology and Epilepsy, MCP-Hahnemann University School of Medicine, Medical College of Pennsylvania Hospital, 3300 Henry Avenue, Philadelphia, PA 19129, USA. mj26@exchange1.drexel.edu

Current Treatment Options in Neurology
|December 6, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025

Managing epilepsy in older adults presents unique challenges due to increased seizure risk and medication sensitivities. Careful anti-epileptic drug (AED) selection is crucial for effective seizure control and quality of life.

Area of Science:

  • Geriatric Neurology
  • Clinical Pharmacology
  • Epilepsy Management

Background:

  • Older adults face unrecognized increased seizure risks.
  • Epilepsy in this demographic may be milder, with unique dosing challenges.
  • Polypharmacy and altered physiological functions complicate anti-epileptic drug (AED) therapy.

Purpose of the Study:

  • To highlight the specific challenges in managing seizures and epilepsy in the elderly population.
  • To discuss the considerations for selecting and dosing anti-epileptic drugs (AEDs) in older adults.
  • To emphasize the importance of managing side effects and optimizing quality of life.

Main Methods:

  • Review of factors influencing AED pharmacokinetics and pharmacodynamics in older adults.
  • Analysis of common seizure types (focal onset) in this age group.

Related Experiment Videos

  • Consideration of polypharmacy, drug interactions, and physiological changes affecting AED treatment.

    • Main Results:

    • Older adults are susceptible to AED side effects like ataxia, somnolence, and confusion.
    • AED selection depends on comorbidities, polypharmacy, and side effect profiles.
    • Monitoring of free and total AED levels may be required for optimal dosing.

    Conclusions:

    • Tailored anti-epileptic drug (AED) strategies are essential for older adults with epilepsy.
    • Balancing rapid seizure control with minimizing side effects is key for outpatient management.
    • Achieving effective seizure management while maintaining quality of life is the primary goal.